New study shows bivalent COVID-19 booster increases antibody response in lung cancer patients Post author: Post published:November 23, 2023 Post category:uncategorized Bivalent booster dose enhanced neutralization of Omicron XBB (sub)variants in non-small cell lung cancer (NSCLC) patients. You Might Also Like Promising role of antidiabetic drug in cancer control June 11, 2024 Functional, nonepileptic seizures linked to higher death rate than expected January 24, 2024 Study finds clues to hypertension hidden in electronic health records April 1, 2025